Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

18.2K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
18.2K
RNA Interference01:23

RNA Interference

27.6K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
27.6K
Experimental RNAi02:15

Experimental RNAi

7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

American Heart Association/American Stroke Association 2026 Guideline for the Early Management of Patients with Acute Ischemic Stroke: Pediatric Perspective.

Indian pediatricsĀ·2026
Same author

Parental autistic traits and neurodevelopmental outcomes in children with autism spectrum disorder: a family phenotype perspective.

Developmental neurorehabilitationĀ·2026
Same author

Behavioral Adverse Effects of Levetiracetam: Pragmatic Research vs Research in Highly Controlled Idealized Settings.

Indian pediatricsĀ·2026
Same author

Behavioral Adverse Effects During Initial Six Weeks of Levetiracetam Therapy in Children with Epilepsy: A Prospective Cohort Study.

Indian pediatricsĀ·2026
Same author

When Content Overwhelms Capability: Time to Think Modular!

Indian pediatricsĀ·2026
Same author

Validating Translated Versions of Developmental Screening Tools: Moving Forward Toward Wider Application.

Indian pediatricsĀ·2025

Related Experiment Video

Updated: Dec 28, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.8K

Antisense Oligonucleotides: A Unique Treatment Approach.

Abhinaya V Krishnan1, Devendra Mishra2

  • 1Department of Pediatrics, Maulana Azad Medical College (University of Delhi), Delhi-110002, India.

Indian Pediatrics
|February 16, 2020
PubMed
Summary

Synthetic Antisense oligonucleotides (ASOs) are DNA analogs that regulate gene expression. This primer explains their mechanisms and clinical applications for pediatricians, offering hope for treating previously incurable diseases.

More Related Videos

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

14.2K
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

19.5K

Related Experiment Videos

Last Updated: Dec 28, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
09:04

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids

Published on: September 21, 2017

9.8K
Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts
07:02

Evaluation of Exon Inclusion Induced by Splice Switching Antisense Oligonucleotides in SMA Patient Fibroblasts

Published on: May 11, 2018

14.2K
Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System
07:47

Intrathecal Delivery of Antisense Oligonucleotides in the Rat Central Nervous System

Published on: October 29, 2019

19.5K

Area of Science:

  • Molecular Biology
  • Genetics
  • Pharmacology

Background:

  • Synthetic Antisense Oligonucleotides (ASOs) are emerging as powerful tools in molecular biology.
  • These single-stranded DNA analogs offer precise control over gene expression.
  • Their recent clinical applications mark a significant advancement in therapeutic strategies.

Purpose of the Study:

  • To provide a foundational understanding of ASOs for pediatricians.
  • To elucidate the mechanisms by which ASOs modulate protein synthesis.
  • To highlight the potential of ASOs in treating previously incurable pediatric diseases.

Main Methods:

  • Review of ASO structure and function.
  • Explanation of gene expression regulation by ASOs.
  • Discussion of current and potential clinical uses.

Main Results:

  • ASOs are synthetic DNA analogs complementary to target RNA.
  • They function by altering protein synthesis through various mechanisms.
  • ASOs represent a promising therapeutic avenue.

Conclusions:

  • ASOs are versatile tools for gene expression regulation.
  • Pediatricians should be aware of ASO technology and its implications.
  • ASOs offer new hope for treating rare and previously untreatable conditions.